Males with lupus nephritis had higher all-cause mortality and proportion of infection-related death compared to females.
There are no significant differences in outcomes post-AMI in patients with systemic lupus erythematosus vs the general population.
Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that the U.S. Food and ...